Catalog Number S-65-150-120-P6 |
Device Problems
Detachment Of Device Component (1104); Positioning Failure (1158)
|
Patient Problem
Vessel Or Plaque, Device Embedded In (1204)
|
Event Date 12/18/2015 |
Event Type
Injury
|
Manufacturer Narrative
|
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The stent remains in the patient and the delivery system was reportedly discarded.Investigation is not yet complete.A follow up report will be submitted with all relevant information.
|
|
Event Description
|
It was reported that the procedure was to treat a lesion in the heavily calcified, tortuous, superficial femoral artery (sfa).There were three stents which had been previously implanted in the sfa.Atherectomy was performed.The lesion was pre-dilated and measured to be 6.5mm.A supera percutaneous transluminal angioplasty (pta) catheter was advanced to the lesion 250mm away from the introducer sheath, and stent deployment seemed to be going well.Suddenly, the stent elongated all the way back to the introducer sheath and the tip of the pta catheter separated.A snare device was not available, so the tip of the pta catheter was embedded into the wall of the vessel, through the space in between the struts, with a balloon.A non-abbott stent delivery system was used to push the deployed supera stent down the vessel to a location that would not impede blood flow to other vessels.This was characterized as the best outcome possible, and there was no adverse patient sequela.Although there was a delay in the procedure, it was not clinically significant.The patient was held for observation overnight as a precaution and discharged two days later on (b)(6) 2015.No additional information was provided.
|
|
Manufacturer Narrative
|
(b)(4).It is indicated that the device is not returning for evaluation; therefore, a failure analysis of the complaint device could not be completed.Based on the reported information, there is no indication of a product quality issue with respect to manufacture, design, or labeling.A conclusive cause for the deployment difficulty could not be determined.The stent elongation, tip separation and additional therapy are due to operational context.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot.Additionally, a review of the complaint history identified no similar incidents from this lot.Based on the information reviewed, there is no indication the issue was caused by, or related to the design, manufacture or labeling of the device.(b)(4).
|
|
Search Alerts/Recalls
|
|